MYELOID MALIGNANCIES
Clinical trials for MYELOID MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new MYELOID MALIGNANCIES trials appear
Sign up with your email to follow new studies for MYELOID MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can donor immune cells tame stem cell transplant risks?
Disease control Not yet recruitingThis trial tests whether an experimental cell therapy called agenT-797 is safe for people receiving a stem cell transplant for blood cancers like leukemia or myelodysplastic syndrome. Participants get an infusion of agenT-797 about a week after their transplant. The main goal is …
Matched conditions: MYELOID MALIGNANCIES
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New pill takes on tough blood cancers in first human trial
Disease control Not yet recruitingThis early-stage study tests a new tablet, FXS0683, in 228 adults with blood cancers like lymphoma or leukemia that returned or didn't respond to standard therapy. The main goals are to check safety, find the best dose, and see if the drug shrinks tumors. Participants will be clo…
Matched conditions: MYELOID MALIGNANCIES
Phase: PHASE1 • Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC